Cargando…

Upgrading treatment strategies of cardiovascular diseases using biotechnology: Are we still there?

Detalles Bibliográficos
Autores principales:	Pahlavan, Sara, Abrishami, Sahand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tabriz University of Medical Sciences 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007892/ https://www.ncbi.nlm.nih.gov/pubmed/33815709 http://dx.doi.org/10.34172/jcvtr.2021.19

Ejemplares similares

Why do we still permit tobacco use?
por: Tiffin, Norman H
Publicado: (2015)

Do we still need supertrees?
por: Haeseler, Arndt von
Publicado: (2012)

Why we are still failing to measure the nutrition transition
por: Walls, Helen L, et al.
Publicado: (2018)

Neonatal seizures therapy: we are still looking for the efficacious drug
por: Spagnoli, Carlotta, et al.
Publicado: (2013)

Vita activa in biotechnology: what we do with fungi and what fungi do with us
por: Weinhold, Martin, et al.
Publicado: (2017)

What do we still need to learn on digitally assessed biomarkers?
por: Acs, Balazs, et al.
Publicado: (2021)

Commentary: What do we still have to learn from surgery?
por: Belluschi, Igor, et al.
Publicado: (2021)

Prevalence of primary headaches: it is not the behavior, but still we have to pay attention to it!
por: Pascual, Julio
Publicado: (2011)

Incorporation of Biotechnologies into Gene Banking Strategies to Facilitate Rapid Reconstitution of Populations
por: Blackburn, Harvey D., et al.
Publicado: (2023)

Lung recruitment in ARDS: We are still confused, but on a higher PEEP level
por: Spieth, Peter M, et al.
Publicado: (2012)

Do we still need animals? Surveying the role of animal‐free models in Alzheimer’s and Parkinson’s disease research
por: Aerts, Liesbeth, et al.
Publicado: (2022)

Why we still need drugs for COVID‐19 and can't just rely on vaccines
por: Robinson, Bruce W. S., et al.
Publicado: (2021)

Novel Strategies to Combat CMV-Related Cardiovascular Disease
por: Vasilieva, Elena, et al.
Publicado: (2020)

Commentary: Coronavirus disease 2019 in cardiac surgery: We are still learning and have yet to see all possible complications
por: Ramzy, Danny
Publicado: (2020)

About the complexity of adult onset Still’s disease… and advances still required for its management
por: Guilpain, Philippe, et al.
Publicado: (2017)

Diagnosis and treatment strategy of coronavirus disease 2019 with cardiovascular disease in elderly patients
por: Cheng, Biao
Publicado: (2020)

Cryoballoon ablation: Do we still need real-time recordings?
por: Bisignani, Antonio, et al.
Publicado: (2021)

Relevance of chemistry to white biotechnology
por: Gupta, Munishwar N, et al.
Publicado: (2007)

Microbial Secondary Metabolism and Biotechnology
por: Fouillaud, Mireille, et al.
Publicado: (2022)

Treatment strategies in patients with diabetes and three‐vessel coronary disease: What should we choose?
por: Liang, Bo, et al.
Publicado: (2021)

New challenges and opportunities for industrial biotechnology
por: Chen, Guo-Qiang
Publicado: (2012)

History of gestational diabetes and future cardiovascular disease: What have we learned?
por: Hsu, Cherng‐Lan, et al.
Publicado: (2018)

Identification and treatment of those most at risk for premature atherosclerotic cardiovascular disease: We just cannot seem to get it right
por: Toth, Peter P.
Publicado: (2020)

Acute stroke: we have the treatments and we have the evidence – we need to use them
por: Quinn, Terence J, et al.
Publicado: (2007)

Infertility: still a largely uncovered and undertreated disease
por: Quaas, Alexander M., et al.
Publicado: (2021)

Just Sit Still and Pay Attention?—A Commentary
por: Rosenkranz, Richard R., et al.
Publicado: (2020)

Commentary: Are these times still unprecedented?
por: Chen, Jonathan M.
Publicado: (2021)

Is this (still) a man's world?
por: Metaxa, Victoria
Publicado: (2013)

Yeast biotechnology: teaching the old dog new tricks
por: Mattanovich, Diethard, et al.
Publicado: (2014)

Bioethical Considerations of Advancing the Application of Marine Biotechnology and Aquaculture
por: Harrell, Reginal M.
Publicado: (2017)

Opinions Regarding the Value and Use of the AMCP Format Still Unknown
por: Asche, Carl V.
Publicado: (2007)

Ten myths and twenty years: What we know and what we still do not know about work addiction: Commentary on: Ten myths about work addiction (Griffiths et al., 2018)
por: Kun, Bernadette
Publicado: (2018)

Commentary: “A new hope” in patients with Fontan circulation: High-risk Fontan operation can be done, but for “perfect Fontan” we still aim
por: Kotani, Yasuhiro
Publicado: (2021)

Looking ahead at the potential benefits of biotechnology-derived allergen therapeutics
por: Behrmann, Jason
Publicado: (2007)

Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine
por: Ferrer-Miralles, Neus, et al.
Publicado: (2011)

Cluster Headache is Still Lurking in the Shadows
por: Martelletti, Paolo, et al.
Publicado: (2021)

Is faster still better in therapeutic hypothermia?
por: Howes, Daniel, et al.
Publicado: (2011)

Still a man's world, but why?
por: Weinacker, Ann, et al.
Publicado: (2013)

Urinary prostate specific antigen, usefulness is still a matter of controversy
por: Hekal, Ihab Ahmed
Publicado: (2013)

Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective
por: Lubrano, Ennio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mjpb77227pur2rfljom0b4gjms